What is the proper protocol for administering insulin infusion to a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Give Insulin Infusion

Preparation and Setup

Prepare insulin infusions at a standardized concentration of 1 unit/mL using regular human insulin in 0.9% normal saline, and prime the tubing with 20 mL of waste volume before connecting to the patient. 1

  • Use only regular human insulin for IV administration - other insulin formulations (aspart, glargine, NPH) cause unpredictable pharmacokinetics and are contraindicated for intravenous use 1
  • The 1 unit/mL concentration minimizes dosing errors and allows consistent titration across all critically ill patients 1
  • Priming with 20 mL waste volume is essential because insulin adsorbs to IV tubing material initially, and without priming you will underdose the patient from the start 1

Clinical Indications for IV Insulin

Use IV insulin infusion for hemodynamically unstable patients requiring vasopressors, all patients with type 1 diabetes in critical care, and any situation requiring rapid titration for tight glycemic control. 1

Specific Dosing Protocols:

  • For diabetic ketoacidosis (DKA): Start at 0.1 units/kg/hour as continuous infusion only after confirming serum potassium is adequate (>3.3 mEq/L) 1
  • For general critical care hyperglycemia: Start at 0.5-1 unit/hour with titration based on hourly glucose monitoring 1

Glucose Monitoring During Infusion

Measure blood glucose hourly using point-of-care testing during active titration, targeting 140-180 mg/dL in critically ill patients. 1

  • This target range balances glycemic control against hypoglycemia risk 1
  • Evaluate the amount and timing of carbohydrate intake when calculating insulin requirements and adjust protocols accordingly 1

Transitioning to Subcutaneous Insulin

Administer subcutaneous basal insulin 2 hours before discontinuing the IV infusion to prevent rebound hyperglycemia. 1

Transition Criteria (all must be met):

  • Glucose levels stable <180 mg/dL for 24 hours 1
  • Oral feeding has resumed 1
  • Peripheral edema has resolved 1
  • Patient is off vasopressors 1

Calculating the Subcutaneous Dose:

  • Calculate the basal insulin dose based on the IV insulin infusion rate during the last 6 hours when stable glycemic goals were achieved 1
  • Give the subcutaneous basal insulin 2 hours before stopping the IV infusion to allow adequate absorption and prevent hyperglycemic rebound 1

Common Pitfalls to Avoid

  • Never use insulin analogs (aspart, lispro, glargine, detemir) for IV infusion - only regular human insulin has predictable IV pharmacokinetics 1
  • Never skip the tubing prime - the first 20 mL of insulin solution will be absorbed by the tubing, resulting in significant underdosing 1
  • Never transition to subcutaneous insulin without the 2-hour overlap - this consistently causes rebound hyperglycemia requiring reinitiation of IV insulin 1
  • Never transition while the patient is still hemodynamically unstable - subcutaneous absorption is unpredictable in patients with poor perfusion or on vasopressors 1

References

Guideline

Insulin Infusion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.